Category Archives: Men’s Health

CONCLUSION: In this population-based cohort of older men with castration-resistant prostate cancer, treatment with oral androgen receptor pathway inhibitors was associated with lower estimated risks of all-cause and prostate cancer-specific mortality compared with chemotherapy in patients with and without pre-existing CVD. These findings add real-world comparative effectiveness evidence for patient populations not well represented in randomized clinical trials; however, given the observational…

CONCLUSIONS: Cardiovascular mortality in northern Iran showed an overall statistically significant modest decline over the 13-year period, interrupted by a notable increase coinciding with the COVID-19 pandemic years. Targeted prevention efforts should focus on ischemic heart disease, hypertensive diseases, older adults, and men to further reduce the burden of cardiovascular mortality in the region.

CONCLUSION: Mortality from VHD and DM has risen significantly over 25 years, with persistent disparities. Men, NH Whites, and rural residents bear disproportionate burdens. Early diagnosis, timely intervention, and equitable care access are crucial to address these inequities.

BACKGROUND: Whether differences in sex hormones influence cancer risk in men remains uncertain. We aimed to clarify the association of circulating testosterone, sex hormone-binding globulin (SHBG), and related hormones with risks of cancer death, incident cancer, and incident prostate cancer by means of individual participant data (IPD) meta-analyses.

CONCLUSION: Future public health research, practice, and policy on incarceration andhealth need to include an intersectional analysis of racism, sexism, and ageism.

CONCLUSION: AF- and obesity-related mortality has increased overall from 1999 to 2024, with higher mortality rates observed in men, White individuals, nonmetropolitan areas, and the Southern US region. These findings highlight the need for continued surveillance and targeted prevention efforts in this population.

CONCLUSIONS: Increasing representation of underrepresented populations in cardiovascular trials requires transparent, accessible communication and trust-centered recruitment strategies. Leveraging trusted healthcare providers and community-based outreach is critical to advancing equity in cardiovascular research.

CONCLUSIONS: Rare but life-threatening ischemic and malignant arrhythmic AEs associated with PFA underscore the need for structured surveillance and standardized reporting. A deeper understanding of the underlying mechanisms will be essential to identify patients at risk and guide future studies aimed at further improving the safety of PFA.

CONCLUSIONS AND RELEVANCE: In this cross-sectional study of US Hispanic/Latino adults, VI and CVD risk factor prevalence varied by ethnic background, and diabetes and cumulative CVD risk factors were associated with VI. The findings provide updated prevalence estimates and support the need for longitudinal studies of causal relationships between VI and CVD risk factors.

CONCLUSIONS: Global T2DM prevalence reflects the interaction of biological, social, and health system processes rather than incidence alone. Prevalence trajectories must be interpreted in light of surveillance limitations, diagnostic context, and within-disease heterogeneity. Addressing future burden requires combining improved detection and chronic-care capacity with upstream, life-course-oriented prevention strategies.